![Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial - The Lancet Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2b1347dc-1a1d-460a-816e-75de4d8c745b/gr1_lrg.gif)
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial - The Lancet
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e28ef43-c740-4fed-8a87-890cd2491360/ntbl004.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. | Semantic Scholar Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/91d492fffeb6fccb22692aada6ec12f670c80729/2-Table2-1.png)
Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. | Semantic Scholar
![Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.347130144/asset/images/medium/rg.347130144.tbl2.gif)
Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation | RadioGraphics
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2487ea26-1e5f-4b40-9ecd-fddbb803589d/ntbl003.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig1_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer | Journal of Ovarian Research | Full Text Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1757-2215-3-22/MediaObjects/13048_2010_Article_52_Fig2_HTML.jpg)
Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer | Journal of Ovarian Research | Full Text
![Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825813010147-t1.jpg)
Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer - ScienceDirect
![Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ Risk of ovarian cancer in women with symptoms in primary care: population based case-control study | The BMJ](https://www.bmj.com/content/bmj/339/bmj.b2998/F2.large.jpg)